The Ministry of Health confirms that the arrival of the swine flu virus resistant to Tamiflu, to Egypt

Saturday, December 5th, 2009

The announcement of WHO on the transmission of swine influenza virus resistant to treatment with Altammivloa for the first time since the discovery of the virus, to open the door to a new wave of evolution of the virus, which experts said was a new virus that no one knows the nature of the prevalence or Thorath and resistance to treatment.
-snip-
The Ministry of Health formed a committee to examine the death of the tenth case, due to the injury of swine flu, which was suspected of resistance to treatment Baltammivloa, but it has not yet been proved.

The WHO has indicated in published urgent this morning, it had registered for the first time two cases of infection caused by H1N1 viruses resistant to oseltamivir, the scientific name of the property wizard to swine influenza virus to "Altammivloa."

The first group launched by [snip] "and Wales" which was recorded in England, which was unveiled in late October last eight patients, was the introduction of all these patients to the hospital because of bloody unrest and tent. Has not been recorded any deaths among them so far, note that being treated and one of them in the intensive care ward.

The second group is a United States of America, which included four patients with a general shortage of Immunology, The cases occurred over two weeks in the period between mid-October and early November of last November, has resulted in three cases of a total of four cases of death, but that uncertainty does not continues to control the extent to which the H1N1 virus in the occurrence of such deaths.

Included all viruses H275Y resistance mutation itself, which refers to the resistance to the drug oseltamivir treatment of influenza first mutated and sensitivity about zanamivir, a drug the second anti-virus software.

The World Health Organization, once receiving reports, to organize a telephone conference with officials of the hospitals and their staff and experts in the fields of clinical medicine, epidemiology and virology to discuss the outbreaks mentioned, calling attention therapeutic options that can be made available to the immunocompromised patients who are infected with HIV pandemic.